Trial intelligence / Profile preview

Synvisc One vs placebo in symptomatic knee osteoarthritis (China)

CTR20170202Phase 3Completed

Sponsor
Sanofi
Start
Jul 2017
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of sodium hyaluronate in knee osteoarthritis (OA), sponsored by Sanofi. Started Jul 2017; status: completed.

02

Drugs

sodium hyaluronate
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on CTR20170202.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20170202.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call